Evidence map›Paper›PMID 33462257›Full record

ArticleScientific reports2021

Author Correction: Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors.

Takayuki Hamabata, Katsutsugu Umeda, Kagehiro Kouzuki, Takayuki Tanaka, Tomoo Daifu, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Shiro Baba, Hidefumi Hiramatsu and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Takayuki HamabataDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Katsutsugu UmedaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan. umeume@kuhp.kyoto-u.ac.jp.
Kagehiro KouzukiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Takayuki TanakaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Tomoo DaifuDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Seishiro NodomiDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Satoshi SaidaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Itaru KatoDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.ORCID http://orcid.org/0000-0002-2932-4960
Shiro BabaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Hidefumi HiramatsuDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Mitsujiro OsawaDepartment of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
Akira NiwaDepartment of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
Megumu K SaitoDepartment of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0001-8813-3614
Yasuhiko KamikuboDepartment of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Souichi AdachiDepartment of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Yoshiko HashiiDepartment of Cancer Immunotherapy, Osaka University School of Medicine, Suita, 565-0871, Japan.
Akira ShimadaDepartment of Pediatric Hematology/Oncology, Okayama University, Okayama, 700-8558, Japan.
Hiroyoshi WatanabeDepartment of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, 770-8501, Japan.
Kenji OsafuneDepartment of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0001-7238-2763
Keisuke OkitaDepartment of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.ORCID http://orcid.org/0000-0001-5806-1090
Tatsutoshi NakahataDrug Discovery Technology Development Office, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
Kenichiro WatanabeDepartment of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, 420-8660, Japan.
Junko TakitaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.
Toshio HeikeDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Shogoin, 606-8507, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33462257
PMCPMC7814114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.